Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that selectively binds to PD-1 at low concentrations and shows high activity. Spartalizumab blocks the interaction with PD-L1 and PD-L2, and can be used to study undifferentiated
CAS Number:
[1935694-88-4]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted